"La Fondazione Istituto Neurologico Casimiro Mondino di Pavia. La fondazione Istituto Neurologico Casimiro Mondino è configurata giuridicamente come Istituto di Ricovero e Cura a Carattere Scientifico di diritto privato. La Fondazione Istituto Neurologico Casimiro Mondino è specializzata nella diagnosi e cura del sistema nervoso. La Fondazione Istituto Neurologico Casimiro Mondino di Pavia cura le seguenti patologie: cefalee, epilessie, disturbi del sonno, disfagie neurogene, malattie cerebrovascolari, neuromuscolari, di Parkinson, sclerosi multipla e neuropsichiatria infantile. La Fondazione Istituto Neurologico Casimiro Mondino dedica particolare attenzione al proprio personale sia medico sia tecnico ed infermieristico."

During the past decade, Fondazione Istituto Neurologico Casimiro Mondino conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Istituto Neurologico Casimiro Mondino" #1 sponsor was "Amgen" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "H. Lundbeck A/S" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Baxalta now part of Shire" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Istituto Neurologico Casimiro Mondino" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Fondazione Istituto Neurologico Casimiro Mondino" with 1 trials as a collaborator, "Medical Health Research Infrastructure Council, Australia" with 1 trials as a collaborator and "National Health and Medical Research Council, Australia" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Istituto Neurologico Casimiro Mondino" are "Migraine" (7 trials), "Chronic Cluster Headache" (2 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Epilepsy, Partial Seizures" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Fondazione Istituto Neurologico Casimiro Mondino" in a lesser frequency.

Most popular intervention types in "Fondazione Istituto Neurologico Casimiro Mondino" are "Drug" (23 trials), "Other" (5 trials), "Device" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Eptinezumab" (3 trials), "Lasmiditan" (3 trials), "Erenumab Dose 1" (2 trials) and "Erenumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Istituto Neurologico Casimiro Mondino" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione Istituto Neurologico Casimiro Mondino". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Fondazione Istituto Neurologico Casimiro Mondino, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Istituto Neurologico Casimiro Mondino, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Fondazione Istituto Neurologico Casimiro Mondino has several departments that took part in Clinical trials: "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla" - 6 trials, "ASST di Pavia - Fondazione Istituto Neurologico Mondino IRCCS" - 4 trials, "Struttura Semplice Neuropsicologia Clinica/ Centro UVA" - 3 trials, "Dipartimento di Clinica Neurologica e Psichiatrica dell'Eta Evolutiva della Fondazione IRCCS "C. Mondino" di Pavia" - 2 trials, "U.O. di Neuropsichiatria Infantile Fondazione Istituto Neurologico Nazionale Casimiro Mondino Istituto di Ricovero e Cura a Carattere Scientifico" - 2 trials